Researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other for diagnosed patients who do not require a hospital stay.
Other News
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…
I’m young and healthy, why should I get vaccinated? In the United States, we have a long history of helping each other. If a river is…
We’re a month away from the start of classes for the 2021/22 Academic Year and I believe we are all looking forward to seeing colleagues…